Navigation Links
Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
Date:5/24/2013

e care to ensure that such is the case), the information contained in this announcement for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information.

The managing member of RP Management accepts responsibility for the information contained in this announcement, save that the only responsibility accepted by the managing member of RP Management in respect of the information in this announcement relating to Elan, the Elan Group, the Board of Elan and the persons connected with them, which has been compiled from published sources, has been to ensure that such information has been correctly and fairly reproduced or presented (and no steps have been taken by the managing member of RP Management to verify this information). To the best of the knowledge and belief of the managing member of RP Management (having taken all reasonable care to ensure that such is the case), the information contained in this announcement for which he accepts responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information.

Other

J.P. Morgan, together with its affiliate J.P. Morgan Cazenove (which is authorised and regulated by the Financial Conduct Authority in the United Kingdom), is acting exclusively for Royalty Pharma and RP Management in connection with the matters described in this announcement and for no one else, and is not, and will not be, responsible to anyone other than Royalty Pharma and RP Management for providing the protections afforded to clients of J.P. Morgan or its affiliates, or for providing advice in relation to the Increased Offer or any other matters referred to in this announcement.

BofA Merrill Lynch, together with its affiliate Merrill Lynch International (which is authorised and regulated by the Financial Conduct Authority in the United Kingdom), is a
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
2. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
3. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
4. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
5. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
6. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
7. Royalty Pharma Announces Proposal To Acquire Elan
8. Royalty Rates Take Center Stage in Biopharma Dealmaking
9. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
10. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
11. Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015  Elekta has CE ... Monaco® treatment planning system , enabling European clinics to ... major treatment techniques including advanced 3D planning, IMRT, VMAT ... Monaco ® ... well improved workflow efficiency. Advancements in 3D planning as ...
(Date:4/23/2015)... Calif., April 23, 2015  Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, today reported net income ... or $1.12 per diluted share.  Net income for the ... $0.56 per diluted share, and non-GAAP net income was ... Net sales for the quarter ended March 31, 2015 increased ...
(Date:4/23/2015)... - Health Canada is working with the Canadian manufacturers ... information regarding the risk of serious cardiovascular side effects ... used at high doses (at or above 2400 mg/day). ... Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) ... inflammation. The majority of ibuprofen products in ...
Breaking Medicine Technology:Elekta CE marks for Monaco v5.10 treatment planning system 2Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 2Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 3Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 4
... Corporation ("Futuremed") (TSX: FMD) and Cardinal Health Canada Inc. ... Inc. (NYSE: CAH ), announced today that ... morning regarding Cardinal Health Canada,s proposed acquisition of all ... for CAD $8.15 per Common Share in cash (the ...
... WORTH, Texas, February 16, 2012 Medical ... in Fort Worth, Texas on March 14-15, 2012. In ... and MD&M East (Philadelphia, PA), MD&M Texas Conference is ... device design and development presented by experienced medtech industry ...
Cached Medicine Technology:Cardinal Health Canada Inc. Receives Competition Bureau Clearance for Acquisition of Futuremed 2Cardinal Health Canada Inc. Receives Competition Bureau Clearance for Acquisition of Futuremed 3Cardinal Health Canada Inc. Receives Competition Bureau Clearance for Acquisition of Futuremed 4Medical Design & Manufacturing Conference to be Launched in Texas in March 2012 2
(Date:4/24/2015)... (PRWEB) April 24, 2015 Olive Fertility ... Olive Fertility co-founder and co-director, has been honoured for ... at the Evening of Hope Gala. , “We ... Dr. Albert Yuzpe, who has been at the forefront ... years,” says Jessica Séguin, Executive Director of Fertile Futures--a ...
(Date:4/24/2015)... April 24, 2015 With years of ... UGA is now proud to be partnered with a ... 16,000 animals a year. This partnership has brought new ... animals. , After providing an in-house payment plan ... Teaching Hospital (VMTH) wanted to increase financing options available ...
(Date:4/24/2015)... ON (PRWEB) April 24, 2015 ... safe, informed and legal access to medical cannabis, is ... are properly supported when advising patients. , NAC is ... Certificate Program. With a $250,000 grant, NAC will be ... program. , "Our goal is to help Canadians gain ...
(Date:4/24/2015)... “ Opera ” was featured on NewsWatch as ... and coolest technology products available to consumers. Andrew Tropeano, a ... and shared with viewers how this is the fastest way ... internet would not be in existence. But each web browser ... is no different. Celebrating their 20th anniversary this year, Opera ...
(Date:4/24/2015)... Telematics Berlin is the foremost Automotive Data event in ... content providers, associations and government bodies. From industry critical ... them converge in Berlin. This year’s start-up competition is ... currently at the forefront of Europe’s Silicon Valley but ... products, ParkTAG are one of the first social parking ...
Breaking Medicine News(10 mins):Health News:Olive Fertility Centre Co-founder, Dr Al Yuzpe, Recognized as a Pioneer in Fertility Preservation 2Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2Health News:A Web Browser That Connects over 350 Million People was Featured on NewsWatch Television 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3
... , TUESDAY, Aug. 30 (HealthDay News) -- ... making informed health care decisions. The Agency for ... free, easy-to-understand pamphlets on six health-related topics, including the ... new Spanish-language guide on heart medications is part of ...
... News) -- Genes affect hereditary coronary heart disease risk but ... While it,s long been known that hereditary factors influence this ... genes or unhealthy lifestyle in the family, the Swedish researchers ... examined the health records of 80,214 adopted men and women ...
... show up to appointments with hypertension expert John Bisognano, M.D., ... will help lower their blood pressure. And like most physicians, ... good, or if they will cause any harm. ... number of people want to avoid standard pharmaceuticals," said Bisognano, ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, Aug. ... circulating in the blood which seems to be a harbinger ... The protein, cathepsin S, is strongly tied to the inflammatory ... heart disease. The authors of the new study, published ...
... HealthDay Reporter , MONDAY, Aug. 29 (HealthDay News) -- ... than patient preschoolers to grow into adults who lack ... is that there are some individuals who consistently presented ... Casey, a cognitive neuroscientist at the Sackler Institute for ...
... of improved management at the acute stage, the risk ... decreased by about 50% in the past 10 years. ... hospital, has resulted in improved survival and fewer recurrent ... try and further decrease long-term mortality in patients who ...
Cached Medicine News:Health News:U.S. Offers Health-Care Pamphlets in Spanish 2Health News:Beyond pills: Cardiologists examine alternatives to halt high blood pressure 2Health News:Beyond pills: Cardiologists examine alternatives to halt high blood pressure 3Health News:Blood Protein Might Signal Death Risk in Elderly 2Health News:'Gimme' Kids Often Grow Into 'Gimme' Adults 2Health News:'Gimme' Kids Often Grow Into 'Gimme' Adults 3Health News:What do patients receiving optimal medical therapy after a heart attack die from? 2
... The CellTracks® Analyzer ... fluorescence microscope used to ... that are immunomagnetically selected ... consists of the CellTracks® ...
... These unique Acid Fast ... sputum smear with appropriate background ... containing a positive and negative ... Kinyoun (Cat. No. 353), Ziehl-Neelsen ...
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
Medicine Products: